{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T12:10:16Z","timestamp":1733487016615,"version":"3.30.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Science Advances"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pscia.2024.100053","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T01:34:04Z","timestamp":1726191244000},"page":"100053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sos1 deficiency ameliorates oncogenic KRAS-mediated hematopoietic stem cell exhaustion and myeloid progenitor expansion"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8567-1644","authenticated-orcid":false,"given":"Maoshuo","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6167-6835","authenticated-orcid":false,"given":"Sijia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9996-1466","authenticated-orcid":false,"given":"Xiaona","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pscia.2024.100053_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1556-0864(15)31506-9","article-title":"The Ras\/Raf\/MAPK pathway","volume":"1","author":"Molina","year":"2006","journal-title":"J.\u00a0Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.pscia.2024.100053_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.pscia.2024.100053_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions","volume":"24","author":"Bolouri","year":"2018","journal-title":"Nat. Med."},{"issue":"7696","key":"10.1016\/j.pscia.2024.100053_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"issue":"7696","key":"10.1016\/j.pscia.2024.100053_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pscia.2024.100053_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","article-title":"Juvenile myelomonocytic leukemia: who's the driver at the wheel?","volume":"133","author":"Niemeyer","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.pscia.2024.100053_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","article-title":"RAS diseases in children","volume":"99","author":"Niemeyer","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.pscia.2024.100053_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","article-title":"How I treat juvenile myelomonocytic leukemia","volume":"125","author":"Locatelli","year":"2015","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.pscia.2024.100053_bib9","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","article-title":"Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition","volume":"124","author":"Irving","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.pscia.2024.100053_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc2960","article-title":"Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?","volume":"10","author":"Vigil","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.pscia.2024.100053_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00149-1","article-title":"Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS","volume":"112","author":"Margarit","year":"2003","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.pscia.2024.100053_bib12","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood-2018-09-874107","article-title":"Unique dependence on Sos1 in Kras (G12D) -induced leukemogenesis","volume":"132","author":"You","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pscia.2024.100053_bib13","first-page":"1417","article-title":"MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes","volume":"11","author":"Rozakis-Adcock","year":"1995","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.pscia.2024.100053_bib14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1182\/blood.2021012519","article-title":"Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation","volume":"139","author":"You","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pscia.2024.100053_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2010-12-326058","article-title":"Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pscia.2024.100053_bib16","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1172\/JCI74182","article-title":"Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm","volume":"124","author":"Kong","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"issue":"26","key":"10.1016\/j.pscia.2024.100053_bib17","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1182\/blood-2010-04-281527","article-title":"Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic\/monocytic precursors in a murine model of chronic myelomonocytic leukemia","volume":"116","author":"Wang","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pscia.2024.100053_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/stem.1127","article-title":"Signaling profiling at the single-cell level identifies a distinct signaling signature in murine hematopoietic stem cells","volume":"30","author":"Du","year":"2012","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.pscia.2024.100053_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/leu.2012.251","article-title":"Loss of CD44 attenuates aberrant GM-CSF signaling in Kras G12D hematopoietic progenitor\/precursor cells and prolongs the survival of diseased animals","volume":"27","author":"Du","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.pscia.2024.100053_bib20","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood-2008-01-134262","article-title":"Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pscia.2024.100053_bib21","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/leu.2016.40","article-title":"Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesis","volume":"30","author":"Kong","year":"2016","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.pscia.2024.100053_bib22","doi-asserted-by":"crossref","first-page":"15856","DOI":"10.1021\/acs.jmedchem.2c01517","article-title":"Design and structural optimization of orally bioavailable SOS1 inhibitors for the treatment of KRAS-driven carcinoma","volume":"65","author":"Zhang","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.pscia.2024.100053_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1158\/1535-7163.MCT-23-0513","article-title":"Cereblon-based bifunctional degrader of SOS1, BTX-6654, targets Multiple KRAS mutations and inhibits tumor growth","volume":"23","author":"Begovich","year":"2024","journal-title":"Mol. Cancer Therapeut."}],"container-title":["Pharmaceutical Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216924000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216924000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:55:31Z","timestamp":1733486131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773216924000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":23,"alternative-id":["S2773216924000199"],"URL":"https:\/\/doi.org\/10.1016\/j.pscia.2024.100053","relation":{},"ISSN":["2773-2169"],"issn-type":[{"type":"print","value":"2773-2169"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sos1 deficiency ameliorates oncogenic KRAS-mediated hematopoietic stem cell exhaustion and myeloid progenitor expansion","name":"articletitle","label":"Article Title"},{"value":"Pharmaceutical Science Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscia.2024.100053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Shandong University.","name":"copyright","label":"Copyright"}],"article-number":"100053"}}